|
|
Volumn 62, Issue 11, 2005, Pages 1689-1693
|
|
Treatment of myasthenia gravis exacerbation with intravenous immunoglobulin: A randomized double-blind clinical trial
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ASPARTATE AMINOTRANSFERASE;
CREATININE;
IMMUNOGLOBULIN;
ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD;
ADOLESCENT;
ADULT;
AGED;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
ARTICLE;
ASPARTATE AMINOTRANSFERASE BLOOD LEVEL;
CHILL;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONFIDENCE INTERVAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CREATININE BLOOD LEVEL;
DISEASE EXACERBATION;
DOSE CALCULATION;
DOUBLE BLIND PROCEDURE;
DRUG DOSE REGIMEN;
DRUG FEVER;
DRUG INDUCED HEADACHE;
FEMALE;
HEADACHE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
MYALGIA;
MYASTHENIA GRAVIS;
NAUSEA;
PATIENT MONITORING;
PRIORITY JOURNAL;
RANDOMIZATION;
RANDOMIZED CONTROLLED TRIAL;
SAMPLE SIZE;
SCORING SYSTEM;
SKIN MANIFESTATION;
VOMITING;
ADOLESCENT;
ADULT;
AGED;
AGED, 80 AND OVER;
DOUBLE-BLIND METHOD;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMANS;
IMMUNOGLOBULINS, INTRAVENOUS;
MALE;
MIDDLE AGED;
MYASTHENIA GRAVIS;
NEUROLOGIC EXAMINATION;
RETROSPECTIVE STUDIES;
STATISTICS, NONPARAMETRIC;
TIME FACTORS;
TREATMENT OUTCOME;
|
|
EID: 27744586691
PISSN: 00039942
EISSN: 15383687
Source Type: Journal
DOI: 10.1001/archneur.62.11.1689 Document Type: Article |
|
Times cited : (164)
|
|
References (5)
|
